Brain imaging of 18F-fallypride in normal volunteers: blood analysis, distribution, test-retest studies, and preliminary assessment of sensitivity to aging effects on dopamine D-2/D-3 receptors
- PMID: 12325044
- DOI: 10.1002/syn.10128
Brain imaging of 18F-fallypride in normal volunteers: blood analysis, distribution, test-retest studies, and preliminary assessment of sensitivity to aging effects on dopamine D-2/D-3 receptors
Abstract
Human studies of dopamine D2/D3 receptors using 18F-fallypride-PET in normal volunteers were performed to evaluate brain distribution in striatal and extrastriatal regions, evaluate metabolites in blood plasma, establish PET imaging protocol for this new radiotracer, evaluate graphical methods of analysis to quantitate D2/D3 receptors, and assess the ability of 18F-fallypride to measure changes in D2/D3 receptors with aging as a model. Subjects (6; 21-63 years) had a PET scan on a Siemens HR+ scanner with 18F-fallypride and a T1-weighted MRI scan on a 1.5T GE scanner for purposes of anatomical coregistration with PET. A 3-h PET scan with 18F-fallypride (0.07 mCi/Kg) was carried out on each subject and repeated in 4-6 weeks. Arterial or arterialized venous blood was obtained in all subjects in order to evaluate blood activity levels and analyze metabolites in the plasma. Brain regions-of-interest were identified and drawn using PET and PET-MR coregistered images. PET data was analyzed using graphical methods in which cerebellum was used as the reference region providing distribution volume ratios (DVR) from which binding potential (BP) was derived and used as a measure of concentration of receptors. Distribution of 18F-fallypride was consistent in all subjects studied and the rank order of receptor concentration was putamen > caudate > thalamus = pituitary > amygdala > colliculi > substantia nigra > hippocampus = temporal cortex > parietal cortex = occipital cortex = orbitofrontal cortex. For younger subjects, BP ranged from 37 for the putamen to 0.4 for orbitofrontal cortex, with a test-retest error of about 10%. Both hydrophilic and lipophilic metabolites were observed in arterial blood plasma and analyses showed approx. 30-40% of plasma radioactivity at 3 h was 18F-fallypride. With aging, all brain regions exhibited a significant decrease (>10% per decade) in binding of 18F-fallypride. PET studies with 18F-fallypride are thus suitable to study changes in D2/D3 receptors in striatal and extrastriatal brain regions.
Copyright 2002 Wiley-Liss, Inc.
Similar articles
-
Measurement of d-amphetamine-induced effects on the binding of dopamine D-2/D-3 receptor radioligand, 18F-fallypride in extrastriatal brain regions in non-human primates using PET.Brain Res. 2005 Jan 25;1032(1-2):77-84. doi: 10.1016/j.brainres.2004.11.005. Brain Res. 2005. PMID: 15680944
-
Preliminary assessment of extrastriatal dopamine D-2 receptor binding in the rodent and nonhuman primate brains using the high affinity radioligand, 18F-fallypride.Nucl Med Biol. 1999 Jul;26(5):519-27. doi: 10.1016/s0969-8051(99)00012-8. Nucl Med Biol. 1999. PMID: 10473190
-
Decreased dopamine D2/D3-receptor binding in temporal lobe epilepsy: an [18F]fallypride PET study.Epilepsia. 2006 Aug;47(8):1392-6. doi: 10.1111/j.1528-1167.2006.00561.x. Epilepsia. 2006. PMID: 16922886
-
The discovery of epidepride and its analogs as high-affinity radioligands for imaging extrastriatal dopamine D(2) receptors in human brain.Curr Pharm Des. 2003;9(8):673-96. doi: 10.2174/1381612033391135. Curr Pharm Des. 2003. PMID: 12570798 Review.
-
(S)-N-((1-Allyl-2-pyrrolidinyl)methyl)-5-(3-[18F]fluoropropyl)-2-methoxybenzamide.2006 Aug 3 [updated 2008 May 17]. In: Molecular Imaging and Contrast Agent Database (MICAD) [Internet]. Bethesda (MD): National Center for Biotechnology Information (US); 2004–2013. 2006 Aug 3 [updated 2008 May 17]. In: Molecular Imaging and Contrast Agent Database (MICAD) [Internet]. Bethesda (MD): National Center for Biotechnology Information (US); 2004–2013. PMID: 20641474 Free Books & Documents. Review.
Cited by
-
[18F]Flotaza for Aβ Plaque Diagnostic Imaging: Evaluation in Postmortem Human Alzheimer's Disease Brain Hippocampus and PET/CT Imaging in 5xFAD Transgenic Mice.Int J Mol Sci. 2024 Jul 18;25(14):7890. doi: 10.3390/ijms25147890. Int J Mol Sci. 2024. PMID: 39063132 Free PMC article.
-
Increasing striatal dopamine release through repeated bouts of theta burst transcranial magnetic stimulation of the left dorsolateral prefrontal cortex. A 18F-desmethoxyfallypride positron emission tomography study.Front Neurosci. 2024 Jan 18;17:1295151. doi: 10.3389/fnins.2023.1295151. eCollection 2023. Front Neurosci. 2024. PMID: 38304075 Free PMC article.
-
Design and Synthesis of D3R Bitopic Ligands with Flexible Secondary Binding Fragments: Radioligand Binding and Computational Chemistry Studies.Molecules. 2023 Dec 24;29(1):123. doi: 10.3390/molecules29010123. Molecules. 2023. PMID: 38202706 Free PMC article.
-
Accentuated Paralimbic and Reduced Mesolimbic D2/3-Impulsivity Associations in Parkinson's Disease.J Neurosci. 2023 Dec 13;43(50):8733-8743. doi: 10.1523/JNEUROSCI.1037-23.2023. J Neurosci. 2023. PMID: 37852792 Free PMC article.
-
The Role of a Dopamine-Dependent Limbic-Motor Network in Sensory Motor Processing in Parkinson Disease.J Cogn Neurosci. 2023 Nov 1;35(11):1806-1822. doi: 10.1162/jocn_a_02048. J Cogn Neurosci. 2023. PMID: 37677065 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical